- 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:phospho-AMPK()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:AMPK()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:phospho-Akt()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:Akt()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:phospho-p38()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:p38()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:phospho-ERK1/2()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
                                        
                                            
                                                Journal: Cardiovascular Diabetology
                                                 引用产品:ERK1/2()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.948
                                                
                                                SpeciesMouse
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
MicroRNA‐30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2
                                        
                                            
                                                Journal: Journal Of Pathology
                                                 引用产品:anti-p27 antibody()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.942
                                                
                                                SpeciesHuman
                                                
                                             
                                         
                                     
                                
                                    - 
                                        
MicroRNA‐30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2
                                        
                                            
                                                Journal: Journal Of Pathology
                                                 引用产品:anti-p21 antibody()
                                                  
                                            
                                            
                                                ApplicationWB
                                                IF5.942
                                                
                                                SpeciesHuman